This study aimed to investigate the potential for using the phosphatase and tensin homolog (PTEN) gene as a prognostic marker in post‐prostatectomy patients with castration‐sensitive prostate cancer (PCa). The gene discussed is PTEN; the disease is Familial prostate cancer.